uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Cdc42, Rac1, and the Wiskott-Aldrich syndrome protein are involved in the cytoskeletal regulation of B lymphocytes.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm, Ludwig Institute for Cancer Research.
Show others and affiliations
2001 (English)In: Blood, ISSN 0006-4971, E-ISSN 1528-0020, Vol. 98, no 4, 1086-1094 p.Article in journal (Refereed) Published
Abstract [en]

Patients with the immunodeficiency disorder Wiskott-Aldrich syndrome (WAS) have lymphocytes with aberrant microvilli, and their T cells, macrophages, and dendritic cells are impaired in cytoskeletal-dependent processes. WAS is caused by a defective or a missing WAS protein (WASP). Signal mediators interleukin-4 (IL-4) and CD40 are important for actin-dependent morphology changes in B cells. A possible function of WASP and its interacting partners, Cdc42 and Rac1, was investigated for these changes. It was found that active Cdc42 and Rac1 induced filopodia and lamellipodia, respectively, in activated B cells. Evidence is given that IL-4 has a specific role in the regulated cycling of Cdc42 because IL-4 partially and transiently depleted active Cdc42 from detergent extract of activated B cells. WASP-deficient B lymphocytes were impaired in IL-4-- and CD40-dependent induction of polarized and spread cells. Microvilli were expressed on WASP-deficient B cells, but they appeared shorter and less dense in cell contacts than in wild-type cells. In conclusion, evidence is provided for the involvement of Cdc42, Rac1, and WASP in the cytoskeletal regulation of B lymphocytes. Aberrations in WASP-deficient B lymphocytes, described here, provide further evidence that WAS is a cytoskeletal disease of hematopoietic cells.

Place, publisher, year, edition, pages
2001. Vol. 98, no 4, 1086-1094 p.
Keyword [en]
Animals, Antigens; CD40/pharmacology, B-Lymphocytes/cytology/*drug effects/ultrastructure, Cell Adhesion/drug effects, Cell Movement/drug effects, Cell Polarity/drug effects, Cytoskeleton/*drug effects, Interleukin-4/pharmacology, Mice, Mice; Knockout, Microvilli/drug effects, Nerve Tissue Proteins/metabolism, Proteins/*pharmacology/physiology, Research Support; Non-U.S. Gov't, Signal Transduction/drug effects, Wiskott-Aldrich Syndrome/pathology, cdc42 GTP-Binding Protein/drug effects/*pharmacology/physiology, rac1 GTP-Binding Protein/*pharmacology/physiology, rho GTP-Binding Proteins/pharmacology/physiology
National Category
Medical and Health Sciences
URN: urn:nbn:se:uu:diva-73633DOI: 10.1182/blood.V98.4.1086PubMedID: 11493455OAI: oai:DiVA.org:uu-73633DiVA: diva2:101543
Available from: 2005-06-13 Created: 2005-06-13 Last updated: 2013-11-21Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMedhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=11493455&dopt=Citation

Search in DiVA

By author/editor
Aspenström, Pontus
By organisation
Ludwig Institute for Cancer Research
In the same journal
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 171 hits
ReferencesLink to record
Permanent link

Direct link